Best Method for Right Atrial Volume Assessment by Two-Dimensional Echocardiography: Validation with Magnetic Resonance Imaging. Echocardiography, 32, 734-739. presented at the 05/2015. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25231096. (2015).
Longitudinal Clinical Findings and Outcome Among Cryptococcus gattii Patients in British Columbia. Clin Infect Dis, 60, 1368-1376. presented at the 05/2015. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25632012. (2015).
A Randomized 36-Week Crossover Trial Comparing Ranibizumab and Bevacizumab for Diabetic Macular Edema. In 2015 Annual Meeting of The Association for Research in Vision and Ophthalmology (ARVO). presented at the 03/05/2015, Denver, CO. Retrieved from http://www.arvo.org/Annual_Meeting/Past_Annual_Meetings/. (2015).
Two Dimensional Echo Methods for Right Atrial Volume Assesment: Accuracy and Performance Using MRI as Reference. In 66th Annual Meeting of the Canadian Cardiovascular Society. presented at the 17/10/2013, Montreal, Quebec, CN. Retrieved from http://www.ccs.ca/index.php/en/. (2013).
Evaluation of the Age-Related Eye Disease Study Clinical Lens Grading System AREDS Report No. 31. Ophthalmology, 117, 2112-2119.e3. presented at the 11/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20561686. (2010).
Preliminary Assessment of Celecoxib and Microdiode Pulse Laser Treatment of Diabetic Macular Edema. Retina, 30, 459-467. presented at the 03/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20038863. (2010).
Safety and Immunogenicity of a Recombinant Nonglycosylated Erythrocyte Binding Antigen 175 Region II Malaria Vaccine in Healthy Adults Living in an Area Where Malaria is Not Endemic. Clinical and Vaccine Immunology, 17, 1552-1559. presented at the 10/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20702657. (2010).
Safety and immunogenicity of a recombinant nonglycosylated erythrocyte binding antigen 175 Region II malaria vaccine in healthy adults living in an area where malaria is not endemic. Clin Vaccine Immunol, 17(10), 1552-9. presented at the 2010 Oct. doi:10.1128/CVI.00082-10. (2010).
Late Outgrowth Endothelial Progenitor Cells in Patients with Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci, 49, 2696-2708. presented at the 06/2008. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18515596. (2008).
A Double-Masked, Randomized Study to Investigate the Safety and Efficacy of Daclizumab to Treat the Ocular Complications Related to Behçet's Disease. Ocul Immunol Inflamm, 15, 63-70. presented at the 03-04/2007. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17558830. (2007).
Intravitreal Anti-Vascular Endothelial Growth Factor Therapy with Pegaptanib for Advanced Von Hippel-Lindau Disease of the Retina. Retina, 27, 150-158. presented at the 02/2007. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17290195. (2007).
A Randomized, Placebo-Controlled, Double-Masked Clinical Trial of Etanercept for the Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis. Arthritis Rheum, 53, 18-23. presented at the 02/2005. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15696578. (2005).
Intravitreal Anti-VEGF Therapy for Advanced Ocular Disease of Von Hippel-Lindau Disease. presented at the 2004.. (2004).
Horizontal rectus tenotomy in patients with congenital nystagmus (CN): results in ten adults. Ophthalmology, 110, 2097-105. presented at the 2003.. (2003).
The Long-Term Effects of Laser Photocoagulation Treatment in Patients with Diabetic Retinopathy: The Early Treatment Diabetic Retinopathy Follow-up Study. Ophthalmology, 110, 1683-89. presented at the 2003.. (2003).
A multicenter randomized double-masked clinical trial of a new formulation of topical Cysteamine for the treatment of Corneal Cystine Crystals in cystinosis. Brit J Ophthalmol, 87, 28-31. presented at the 2003.. (2003).
A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis. Br J Ophthalmol, 87(1), 28-31. presented at the 2003 Jan. doi:10.1136/bjo.87.1.28. (2003).
4 Year Daclizumab Therapy for Sight Threatening Uveitis. presented at the 2002.. (2002).
Conjunctiva T-Cell subpopulations in Jorgen’s and non-Jorgen’s patients with dry eye. Invest Ophthalmol Vis Sci, 43, 2609-2614. presented at the 2002.. (2002).
Horizontal Rectus Tenotomy in the Treatment of Congenital Nystagmus. presented at the 2002.. (2002).